No as the CRO they will be answering the FDA directly. I am sure since Ifosfamide is already an approved drug the FDA is well aware of any side-effects and how much CiaB will cut down those side-effects. I will trust Dr. Von Hoff's resume over anything mentioned here.
Market Data 
Markets 
AI
